C-3,4,5-Substituted 2,6-Dimethyl-1,4-dihydropyridines
2059
radicals and ABTS radical cation. Bioorg. Med. Chem. 2004, 12 (9), 2459–2468;
c) Nunez-Vergara, L. J.; L o´ pez-Alarc o´ n, C.; Navarrete-Encina, P. A.;
Atria, A. M.; Camargo, C.; Squella, J. A. Electrochemical and EPR characteriz-
(
ation of 1,4-dihydropyridines: Reactivity towards alkyl radicals. Free Rad. Res.
2003, 37 (1), 109–120.
4
5
. (a) Stout, D. M.; Meyers, A. I. Recent advances in the chemistry of dihydropyri-
dines. Chem. Rev. 1982, 82, 223–243; (b) Eisner, U.; Kuthan, J. The chemistry
of dihydropyridines. Chem. Rev. 1972, 72 (1), 1–42.
. (a) Ilavsky, D.; Milata, V. Syntheses and spectral properties of unsymmetrically
3,5-disubstituted 2,6-dimethyl-1,4-dihydropyridines. Collect. Czech. Chem.
Comm. 1996, 61, 1233–1243; (b) Zenouz, A. M.; Oskuie, M. R.; Mollazadeh, S.
Synthesis of novel asymmetrical 1,4-dihydropyridine derivatives. Synth.
Commun. 2005, 35 (22), 2895–2903; (c) Zenouz, A. M.; Allahverdi, S. S.;
Raissossadat, M.; Sadeghi, Q. Synthesis of the C-2 functionalized 1,4-dihydropyr-
idines. Asian J. Chem. 2005, 17 (4), 2639–2643.
6
. L o´ pez-Alarc o´ n, C.; Navarrete, P.; Camargo, C.; Squella, J. A. Nu n˜ ez-Vergara,
L. J. Reactivity of 1,4-dihydropyridines toward alkyl, alkylperoxyl radicals, and
ABTS radical cation. Chem. Res. Toxicol. 2003, 16 (2), 208–215.
7. (a) Velasquez, C.; Vo, D.; Knaus, E. E. Syntheses, calcium channel modulation
effects, and nitric oxide release studies of O-2-alkyl-1-(pyrrolidin-1-yl)-diazen-
1-ium-1,2-diolate-4-aryl(heteroaryl)-1,4-dihydro-2,6-dimethyl-3-nitropyridine-5-
carboxylates. Drug. Dev. Res. 2003, 60 (3), 204–216; (b) Di Stilo, A.; Visentin, S.;
Cena, C.; Gasco, A. M.; Ermondi, G.; Gasco, A. New 1,4-dihydropyridines
conjugated to furoxanyl moieties, endowed with both nitric oxide-like and
calcium channel antagonist vasodilator activities. J. Med. Chem. 1998, 41 (27),
5393–5401.
8
. (a) Satoh, Y.; Ichihashi, M.; Okumura, K. Studies on nivaldipine.1: Synthesis and
structure-activity relationships of 1,4-dihydropyridines containing novel substitu-
ents at the 2-position. Chem. Pharm. Bull. 1991, 39, 3189; (b) Kanno, H.;
Yamaguchi, H.; Okamiya, Y.; Sunakawa, K.; Takeshita, T.; Naruchi, T.
Synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a
4-(disubstituted phenyl) ring and an aminoalkyl ester group: Highly potent and
long-lasting calcium antagonists. Chem. Pharm. Bull. 1992, 40 (8), 2049.
. Mannhold, R. Calcium antagonists: Basic chemical and pharmacological proper-
ties. Drugs of Today 1984, 20 (2), 69–90.
9
1
0. (a) N u´ n˜ ez-Vergara, L. J.; Squella, J. A.; Bollo-Dragnic, S.; Morello, A.;
Repetto, Y.; Aldunate, J.; Letelier, M. Nitro aryl 1,4-dihydropyridine derivatives:
Effects on Trypanosoma cruzi. Comp. Biochem. Physiol. 1997, 118 (1), 105–111;
(
b) N u´ n˜ ez-Vergara, L. J.; Squella, J. A.; Bollo-Dragnic, S.; Mar ´ı n-Catal a´ n, R.;
Pino, L.; D ´ı az, G.; Letelier, M. E. Gen. Pharmacol. 1998, 30 (1), 85;
c) Maya, J. D.; Morello, A.; Repetto, Y.; Tellez, R.; Rodriguez, A.; Zelada, O.;
(
Puebla, P.; Caballero, E.; Medarte, M.; N u´ n˜ ez-Vergara, L. J.; Squella, J. A.;
Bont a´ , M.; Bollo, S.; San Feliciano, A. Effects of 3-chloro-phenyl-1,4-dihydropyr-
idine derivatives on Trypanosome cruzi epimastigotes. Comp. Biochem. Physiol.
2
000, 125C, 103–109; (d) Maya, J. D.; Morello, A.; Repetto, Y.; Rodr ´ı guez, A.;
Puebla, P.; Caballero, E.; Medarde, M.; N u´ n˜ ez-Vergara, L. J.; Squella, J. A.;
Ortiz, M. E.; Fuentealba, J.; San Feliciano, A. Trypanosoma cruzi: Inhibition of
parasite growth and respiration by oxazolo(thiazolo)pyridine derivatives and its
relationship to redox potential and lipophilicity. Exp. Parasitol. 2001, 99, 1–6.